Skip to main content

Rubric Capital Management LP

13F filer · CIK 0001687509
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$10.9BU.S. long equity reported on 13F
Positions8618 new · 13 closed
Net flow last quarter+$1.52BBuys minus sells
Top 10 positions weight46.4%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202686 positions
TLNTalen Energy Corp$1.38B12.70%7.52%Not reportedQ3 2024
FTAIFTAI Aviation Ltd.$812M7.45%2.92%+16.5%Q1 2025
VTRSViatris Inc$543M4.98%2.93%+2.0%Q2 2023
TEVATeva Pharmaceutical Industries Ltd$528M4.84%1.34%+2.1%Q4 2018
GLNGGolar LNG Ltd$457M4.20%9.06%Not reportedQ2 2021
VSTVistra Corp.$285M2.61%0.53%+19.7%Q1 2023
TACTransalta Corp$280M2.57%6.82%+13.8%Q1 2021
FLRFluor Corp$263M2.41%3.70%Not reportedQ4 2021
KNSAKiniksa Pharmaceuticals International, plc$256M2.35%Not reported+6.7%Q3 2021
BGCBGC Group, Inc.$254M2.33%Not reported+2.2%Q3 2023
ZMZoom Communications, Inc.$239M2.19%Not reported+176.3%Q1 2026
GILGildan Activewear Inc.$232M2.13%2.43%+222.4%Q3 2025
ARQTArcutis Biotherapeutics, Inc.$217M1.99%6.59%Not reportedQ2 2022
AMZNAmazon Com Inc$215M1.97%0.01%NewQ2 2026
ROIVRoivant Sciences Ltd.$212M1.95%0.83%+20.0%Q4 2022
ZYMEZymeworks Inc.$183M1.68%9.80%Not reportedQ1 2019
AMCRAmcor plc$180M1.66%0.90%+227.9%Q1 2026
CMPRCIMPRESS plc$178M1.63%7.19%+7.4%Q4 2022
AMRXAmneal Pharmaceuticals, Inc.$176M1.61%3.19%-7.9%Q2 2023
NRIXNurix Therapeutics, Inc.$175M1.61%6.96%+192.2%Q4 2025
MCYMercury General Corp$164M1.51%2.78%-28.5%Q1 2025
PFSIPennyMac Financial Services, Inc.$148M1.36%3.27%+3006.3%Q2 2020
IARTIntegra Lifesciences Holdings Corp$139M1.28%9.97%Not reportedQ3 2024
DKDelek US Holdings, Inc.$137M1.25%4.39%Not reportedQ4 2016
LBTYALiberty Global Ltd.$134M1.23%Not reportedNot reportedQ4 2023
MGTXMeiraGTx Holdings plc$123M1.13%9.66%+30.0%Q1 2025
GEOGeo Group Inc$122M1.12%3.12%+10.4%Q1 2025
LILAKLiberty Latin America Ltd.$122M1.12%Not reported-31.0%Q3 2025
SDGRSchrodinger, Inc.$104M0.95%10.16%+6.7%Q1 2022
ECVTEcovyst Inc.$102M0.94%7.50%-10.1%Q2 2025
LBTYKLiberty Global Ltd.$102M0.93%Not reportedNot reportedQ4 2023
COMPCompass, Inc.$101M0.93%1.09%+119.3%Q4 2025
NWLNewell Brands Inc.$98.2M0.90%3.77%+4.9%Q3 2025
EPCEDGEWELL PERSONAL CARE Co$95.2M0.87%7.69%-11.4%Q4 2025
CXWCoreCivic, Inc.$86.5M0.79%2.88%+38.3%Q1 2025
ARDXArdelyx, Inc.$82.6M0.76%6.50%+770.7%Q3 2023
ENOVEnovis CORP$80.7M0.74%6.78%+59.0%Q3 2025
ADMAAdma Biologics, Inc.$78.2M0.72%4.14%+416.2%Q1 2026
MNKDMannkind Corp$76.7M0.70%5.81%+397.2%Q3 2025
DRVNDriven Brands Holdings Inc.$73.9M0.68%3.21%+76.7%Q1 2026
OPKOpko Health, Inc.$71.7M0.66%6.33%Not reportedQ1 2024
AVOMission Produce, Inc.$70.5M0.65%6.77%+246.5%Q1 2026
ADEAAdeia Inc.$70M0.64%1.93%-50.4%Q4 2022
RNWReNew Energy Global plc$68.8M0.63%Not reportedNot reportedQ1 2022
SSYSStratasys Ltd.$68.5M0.63%9.29%Not reportedQ3 2023
SPRYARS Pharmaceuticals, Inc.$68.4M0.63%8.59%+6.8%Q2 2022
ANDEAndersons, Inc.$68.4M0.63%2.94%+16.8%Q4 2025
PRMBPrimo Brands Corp$65.3M0.60%0.74%-4.0%Q4 2025
SONSonoco Products Co$64.4M0.59%1.16%NewQ2 2026
STUBStubHub Holdings, Inc.$64.4M0.59%Not reportedNot reportedQ4 2025
Q1 2026Reported May 15, 202681 positions
TLNTalen Energy Corp$1.15B12.18%7.94%Not reportedQ3 2024
FTAIFTAI Aviation Ltd.$631M6.69%2.51%-30.4%Q1 2025
GLNGGolar LNG Ltd$497M5.26%9.06%Not reportedQ2 2021
TEVATeva Pharmaceutical Industries Ltd$459M4.87%1.31%-28.6%Q4 2018
VTRSViatris Inc$453M4.79%2.91%+31.4%Q2 2023
TACTransalta Corp$233M2.47%5.99%Not reportedQ1 2021
BGCBGC Group, Inc.$228M2.41%Not reported+11.0%Q3 2023
VSTVistra Corp.$225M2.39%0.44%-25.0%Q1 2023
CEGConstellation Energy Corp$200M2.12%0.20%+6.7%Q2 2025
ARQTArcutis Biotherapeutics, Inc.$195M2.06%6.62%Not reportedQ2 2022
MCYMercury General Corp$190M2.01%3.89%+4.9%Q1 2025
KNSAKiniksa Pharmaceuticals International, plc$181M1.91%Not reported+12.7%Q3 2021
ZYMEZymeworks Inc.$175M1.86%9.58%+21.7%Q1 2019
AKAMAkamai Technologies Inc$149M1.58%0.89%+8.3%Q4 2025
LBTYALiberty Global Ltd.$142M1.51%Not reported+17.3%Q4 2023
ROIVRoivant Sciences Ltd.$139M1.47%0.69%-44.4%Q4 2022
AMRXAmneal Pharmaceuticals, Inc.$137M1.45%3.51%-10.5%Q2 2023
LILAKLiberty Latin America Ltd.$136M1.44%Not reported+44.5%Q3 2025
DKDelek US Holdings, Inc.$121M1.28%4.49%Not reportedQ4 2016
CMPRCIMPRESS plc$119M1.26%6.73%+6.9%Q4 2022
ECVTEcovyst Inc.$117M1.24%8.35%-13.0%Q2 2025
LBTYKLiberty Global Ltd.$109M1.15%Not reported+51.3%Q4 2023
ADEAAdeia Inc.$103M1.09%3.89%Not reportedQ4 2022
EPCEDGEWELL PERSONAL CARE Co$85.4M0.90%8.68%+297.2%Q4 2025
ZMZoom Communications, Inc.$80.5M0.85%Not reportedNewQ1 2026
TDSTelephone & Data Systems Inc$77.9M0.83%1.62%Not reportedQ3 2025
GILGildan Activewear Inc.$77.7M0.82%0.75%+444.4%Q3 2025
IARTIntegra Lifesciences Holdings Corp$73M0.77%9.95%Not reportedQ3 2024
SDGRSchrodinger, Inc.$68.2M0.72%9.53%+43.8%Q1 2022
SPRYARS Pharmaceuticals, Inc.$64.2M0.68%8.06%+29.0%Q2 2022
GEOGeo Group Inc$62.9M0.67%2.80%+7.4%Q1 2025
SSYSStratasys Ltd.$62.5M0.66%9.29%+9.0%Q3 2023
ANDEAndersons, Inc.$61.4M0.65%2.53%-14.9%Q4 2025
MGTXMeiraGTx Holdings plc$60.6M0.64%8.59%+13.4%Q1 2025
ENOVEnovis CORP$55.8M0.59%4.29%Not reportedQ3 2025
OPKOpko Health, Inc.$54.5M0.58%6.30%Not reportedQ1 2024
QDELQuidelOrtho Corp$54.3M0.58%4.86%-12.5%Q3 2023
PRMBPrimo Brands Corp$52.4M0.56%0.77%-23.3%Q4 2025
NWLNewell Brands Inc.$52.3M0.55%3.64%+17.4%Q3 2025
AMCRAmcor plc$50.5M0.53%0.27%NewQ1 2026
RNWReNew Energy Global plc$50.4M0.53%Not reportedNot reportedQ1 2022
PRTAProthena Corp Public Ltd Co$48.6M0.51%9.42%+36.0%Q3 2025
PTGXProtagonist Therapeutics, Inc$45.1M0.48%0.67%Not reportedQ1 2024
TRVITrevi Therapeutics, Inc.$44.3M0.47%2.89%-1.4%Q2 2022
OFIXOrthofix Medical Inc.$42.7M0.45%9.22%Not reportedQ1 2023
COLLCollegium Pharmaceutical, Inc$42.3M0.45%3.95%-14.5%Q1 2020
CXWCoreCivic, Inc.$38.9M0.41%2.08%+5.0%Q1 2025
NRIXNurix Therapeutics, Inc.$38.3M0.41%2.39%Not reportedQ4 2025
DRVNDriven Brands Holdings Inc.$37.8M0.40%1.82%NewQ1 2026
CVGWCalavo Growers Inc$36.5M0.39%7.93%NewQ1 2026
Q4 2025Reported Feb 13, 202675 positions
TLNTalen Energy Corp$1.35B16.15%7.88%Not reportedQ3 2024
FTAIFTAI Aviation Ltd.$728M8.71%3.61%+10.1%Q1 2025
TEVATeva Pharmaceutical Industries Ltd$667M7.97%1.86%-13.4%Q4 2018
GLNGGolar LNG Ltd$342M4.08%9.06%Not reportedQ2 2021
VSTVistra Corp.$323M3.86%0.59%Not reportedQ1 2023
VTRSViatris Inc$317M3.80%2.21%+65.8%Q2 2023
ARQTArcutis Biotherapeutics, Inc.$240M2.87%6.71%-23.1%Q2 2022
CEGConstellation Energy Corp$237M2.83%0.21%Not reportedQ2 2025
TACTransalta Corp$225M2.69%5.99%+11.5%Q1 2021
ROIVRoivant Sciences Ltd.$195M2.34%1.27%-55.0%Q4 2022
MCYMercury General Corp$193M2.31%3.71%Not reportedQ1 2025
BGCBGC Group, Inc.$188M2.24%Not reported+16.7%Q3 2023
FLRFluor Corp$164M1.96%2.73%-7.9%Q4 2021
AMRXAmneal Pharmaceuticals, Inc.$155M1.86%3.92%Not reportedQ2 2023
ZYMEZymeworks Inc.$151M1.81%7.70%+22.1%Q1 2019
KNSAKiniksa Pharmaceuticals International, plc$137M1.64%Not reported-16.8%Q3 2021
LBTYALiberty Global Ltd.$112M1.33%Not reported+29.3%Q4 2023
QDELQuidelOrtho Corp$108M1.29%5.56%-18.6%Q3 2023
AKAMAkamai Technologies Inc$105M1.25%0.83%NewQ4 2025
ECVTEcovyst Inc.$102M1.22%9.39%+1.0%Q2 2025
CMPRCIMPRESS plc$102M1.21%6.25%+29.2%Q4 2022
IARTIntegra Lifesciences Holdings Corp$96.3M1.15%9.95%+1.3%Q3 2024
DKDelek US Holdings, Inc.$79.7M0.95%4.48%Not reportedQ4 2016
LILAKLiberty Latin America Ltd.$79.5M0.95%Not reported+3.9%Q3 2025
TDSTelephone & Data Systems Inc$75.9M0.91%1.63%+15.6%Q3 2025
SDGRSchrodinger, Inc.$74.6M0.89%6.62%-20.8%Q1 2022
EOSEEos Energy Enterprises, Inc.$74.5M0.89%1.93%-36.9%Q3 2025
COMPCompass, Inc.$74M0.88%1.24%NewQ4 2025
ADEAAdeia Inc.$73.9M0.88%3.93%Not reportedQ4 2022
SPRYARS Pharmaceuticals, Inc.$72.2M0.86%6.24%+37.8%Q2 2022
COLLCollegium Pharmaceutical, Inc$69.3M0.83%4.72%-47.1%Q1 2020
LBTYKLiberty Global Ltd.$67.6M0.81%Not reported+34.9%Q4 2023
ENOVEnovis CORP$65.4M0.78%4.29%-10.8%Q3 2025
SSYSStratasys Ltd.$63.7M0.76%8.52%-5.9%Q3 2023
ADMArcher-Daniels-Midland Co$63.3M0.76%0.23%NewQ4 2025
RNWReNew Energy Global plc$62.2M0.74%Not reported-23.8%Q1 2022
BGBunge Global SA$60.3M0.72%0.35%+259.2%Q3 2017
OPKOpko Health, Inc.$60.2M0.72%6.23%Not reportedQ1 2024
PRMBPrimo Brands Corp$59.3M0.71%1.00%NewQ4 2025
PRLBProto Labs Inc$56.8M0.68%4.75%Not reportedQ1 2025
OFIXOrthofix Medical Inc.$56.4M0.67%9.34%Not reportedQ1 2023
GEOGeo Group Inc$56.2M0.67%2.56%+16.7%Q1 2025
ANDEAndersons, Inc.$53.5M0.64%2.97%NewQ4 2025
MGTXMeiraGTx Holdings plc$49.1M0.59%7.61%+65.7%Q1 2025
MATVMativ Holdings, Inc.$48.4M0.58%7.28%Not reportedQ3 2022
NWLNewell Brands Inc.$48.4M0.58%3.10%Not reportedQ3 2025
TRVITrevi Therapeutics, Inc.$47.2M0.56%2.94%-55.9%Q2 2022
NRIXNurix Therapeutics, Inc.$46.9M0.56%2.43%NewQ4 2025
MNKDMannkind Corp$42.4M0.51%2.43%-34.5%Q3 2025
HRTXHeron Therapeutics, Inc.$39.1M0.47%15.96%+3.3%Q4 2016
Q3 2025Reported Nov 14, 202569 positions
TLNTalen Energy Corp$1.53B17.29%7.88%-20.1%Q3 2024
FTAIFTAI Aviation Ltd.$561M6.33%3.28%-1.0%Q1 2025
TEVATeva Pharmaceutical Industries Ltd$498M5.62%2.15%-5.2%Q4 2018
GLNGGolar LNG Ltd$371M4.19%8.78%Not reportedQ2 2021
ROIVRoivant Sciences Ltd.$303M3.41%2.90%-1.8%Q4 2022
TACTransalta Corp$218M2.46%5.36%Not reportedQ1 2021
ARQTArcutis Biotherapeutics, Inc.$203M2.29%8.94%Not reportedQ2 2022
FLRFluor Corp$189M2.14%2.79%+12.5%Q4 2021
MCYMercury General Corp$174M1.97%3.71%Not reportedQ1 2025
BGCBGC Group, Inc.$170M1.92%Not reported+5.9%Q3 2023
KNSAKiniksa Pharmaceuticals International, plc$155M1.75%Not reported+2.3%Q3 2021
VTRSViatris Inc$152M1.72%1.32%+28.2%Q2 2023
QDELQuidelOrtho Corp$137M1.54%6.83%Not reportedQ3 2023
AMRXAmneal Pharmaceuticals, Inc.$123M1.39%3.93%+5.3%Q2 2023
EOSEEos Energy Enterprises, Inc.$117M1.32%3.66%NewQ3 2025
RNWReNew Energy Global plc$111M1.25%Not reportedNot reportedQ1 2022
IARTIntegra Lifesciences Holdings Corp$110M1.24%9.82%+4.1%Q3 2024
SDGRSchrodinger, Inc.$106M1.19%8.37%+5.4%Q1 2022
COLLCollegium Pharmaceutical, Inc$98.9M1.12%8.94%-10.5%Q1 2020
ECVTEcovyst Inc.$91.1M1.03%9.12%+120.9%Q2 2025
LBTYALiberty Global Ltd.$88.8M1.00%Not reported+36.2%Q4 2023
SSYSStratasys Ltd.$87.4M0.99%10.88%Not reportedQ3 2023
DKDelek US Holdings, Inc.$86.7M0.98%4.47%Not reportedQ4 2016
LILAKLiberty Latin America Ltd.$86.6M0.98%Not reportedNewQ3 2025
BAXBaxter International Inc$86M0.97%0.74%NewQ3 2025
ENOVEnovis CORP$83.4M0.94%4.81%NewQ3 2025
ZYMEZymeworks Inc.$80.5M0.91%6.27%Not reportedQ1 2019
TRVITrevi Therapeutics, Inc.$78.1M0.88%6.65%Not reportedQ2 2022
CMPRCIMPRESS plc$74.4M0.84%4.79%+110.3%Q4 2022
OPKOpko Health, Inc.$74.1M0.84%6.02%Not reportedQ1 2024
ADEAAdeia Inc.$72M0.81%3.91%Not reportedQ4 2022
NWLNewell Brands Inc.$68.1M0.77%3.10%NewQ3 2025
TDSTelephone & Data Systems Inc$62.8M0.71%1.38%NewQ3 2025
MNKDMannkind Corp$61.3M0.69%3.72%NewQ3 2025
GEOGeo Group Inc$61.2M0.69%2.15%+139.5%Q1 2025
PRLBProto Labs Inc$56.2M0.63%4.74%+8.6%Q1 2025
NFENew Fortress Energy Inc.$54.7M0.62%8.70%+1.5%Q3 2021
OFIXOrthofix Medical Inc.$54.5M0.61%9.42%Not reportedQ1 2023
LBTYKLiberty Global Ltd.$53.3M0.60%Not reported+38.0%Q4 2023
SPRYARS Pharmaceuticals, Inc.$45.2M0.51%4.55%+247.5%Q2 2022
MATVMativ Holdings, Inc.$45M0.51%7.28%Not reportedQ3 2022
CXWCoreCivic, Inc.$39.9M0.45%1.86%+140.6%Q1 2025
ALITAlight, Inc. / Delaware$37.2M0.42%2.55%-41.9%Q2 2024
HRTXHeron Therapeutics, Inc.$36.7M0.41%18.98%+8.9%Q4 2016
MREOMereo BioPharma Group plc$31.5M0.36%1.92%Not reportedQ4 2020
ANIPAni Pharmaceuticals Inc$31.5M0.35%1.63%+33.3%Q4 2021
MGTXMeiraGTx Holdings plc$30.7M0.35%4.63%Not reportedQ1 2025
SCPHScpharmaceuticals Inc.$28.9M0.33%9.57%+10.9%Q2 2023
SUPNSupernus Pharmaceuticals, Inc.$28.5M0.32%1.04%-14.3%Q2 2025
INDVIndivior Pharmaceuticals, Inc.$27.3M0.31%0.91%-75.7%Q4 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.